Back to resultsMobileMedMinder: A Networked Aide for Medication Compliances
Primary Purpose
Heart Failure, Congestive
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Use of MobileMedMinder
Sponsored by
About this trial
This is an interventional other trial for Heart Failure, Congestive
Eligibility Criteria
Inclusion Criteria:
- Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.
Exclusion Criteria:
- Inability to understand informed consent
- Inability to read and understand English
Sites / Locations
- University of Maryland
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Use of MobileMedMinder
Usual care
Arm Description
Outcomes
Primary Outcome Measures
Compliance
Pill counts will be used to assess compliance
Secondary Outcome Measures
Full Information
NCT ID
NCT01597583
First Posted
May 10, 2012
Last Updated
February 23, 2022
Sponsor
University of Maryland, Baltimore
Collaborators
Limaging
1. Study Identification
Unique Protocol Identification Number
NCT01597583
Brief Title
MobileMedMinder: A Networked Aide for Medication Compliances
Official Title
MobileMedMinder: A Networked Aide for Medication Compliances
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
November 2011 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
Limaging
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Congestive
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Use of MobileMedMinder
Arm Type
Experimental
Arm Title
Usual care
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Use of MobileMedMinder
Intervention Description
Use of an intervention to remind patients to take their medications.
Primary Outcome Measure Information:
Title
Compliance
Description
Pill counts will be used to assess compliance
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.
Exclusion Criteria:
Inability to understand informed consent
Inability to read and understand English
Facility Information:
Facility Name
University of Maryland
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
12. IPD Sharing Statement
Learn more about this trial
MobileMedMinder: A Networked Aide for Medication Compliances
We'll reach out to this number within 24 hrs